Isothermal Amplification with a Target-Mimicking Internal Control and Quantitative Lateral Flow Readout for Rapid HIV Viral Load Testing in Low-Resource Settings

Author(s):  
Ian T. Hull ◽  
Enos C. Kline ◽  
Gaurav K. Gulati ◽  
Jack Henry Kotnik ◽  
Nuttada Panpradist ◽  
...  
2017 ◽  
Vol 5 (8) ◽  
pp. e754-e755 ◽  
Author(s):  
Madlen Nash ◽  
John Ramapuram ◽  
Ramya Kaiya ◽  
Sophie Huddart ◽  
Madhukar Pai ◽  
...  

2013 ◽  
Vol 187 (2) ◽  
pp. 248-250 ◽  
Author(s):  
Dominique Goedhals ◽  
Lesley E. Scott ◽  
Serena Moretti ◽  
Mark A. Cooper ◽  
Willem J.L. Opperman ◽  
...  

Author(s):  
Lara Dominique Noble ◽  
Lesley Erica Scott ◽  
Asiashu Bongwe ◽  
Pedro Da Silva ◽  
Wendy Susan Stevens

The tiered laboratory framework for HIV viral load monitoring accommodates a range of HIV viral load testing platforms, with quality assessment critical to ensure quality patient testing. HIV plasma viral load testing is challenged by the instability of viral RNA. An approach using an RNA stabilizing buffer is described for the Xpert HIV-1 Viral Load (Cepheid) assay and was tested in remote laboratories in South Africa. EDTA-plasma panels with known HIV viral titres was prepared in PrimeStore molecular transport medium for per-module verification and per-instrument external quality assessment. The panels were transported at ambient temperature to 13 testing laboratories during 2017-2018, tested according to standard procedures and uploaded to a web portal for analysis A total of 275 quality assessment specimens (57 verification panels and two EQA cycles) were tested. All participants passed verification (n=171 specimens) with an overall concordance correlation (ρc) of 0.997 (95%confidence interval [CI]:0.996,0.998) and a mean log bias of -0.019log cp/mL (95%CI:-0.044,0.063). The overall EQA ρc (n=104 specimens) was 0.999 (95%CI:0.998,0.999), with a mean log bias of 0.03 log cp/mL 95%(CI:0.02,0.05). The panels are suitable for use in quality monitoring of Xpert HIV-1 VL and are applicable to laboratories in remote settings.


PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0212972 ◽  
Author(s):  
M. de Necker ◽  
J. C. de Beer ◽  
M. P. Stander ◽  
C. D. Connell ◽  
D. Mwai

PLoS ONE ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. e0173009 ◽  
Author(s):  
Peter A. Minchella ◽  
Geoffrey Chipungu ◽  
Andrea A. Kim ◽  
Abdoulaye Sarr ◽  
Hammad Ali ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Kelly A. Johnson ◽  
Sally Graglia ◽  
Elizabeth D. Lynch ◽  
Joanna De Mesa ◽  
Erin Antunez ◽  
...  

A 26-year-old male presented to the emergency department feeling unwell in February of 2021 with symptoms including diaphoresis, loose stools, and loss of taste sensation. Workup not only confirmed a diagnosis of COVID-19 but also revealed discordant HIV test results, with a reactive fourth-generation antigen/antibody test but a negative HIV-1/2 differentiation immunoassay. Subsequent HIV viral load testing obtained two days later ultimately established a diagnosis of acute HIV (AHI). Screening for HIV and other sexually transmitted infections decreased during the COVID-19 pandemic. It is critical that providers (1) continue recommended screening for HIV as an essential service; (2) consider acute HIV in the differential when evaluating patients with acute viral syndromes; (3) recognize that AHI can occur concurrently with other infections, including COVID-19; and (4) understand the differential diagnosis for discordant HIV test results and know when HIV viral load testing is needed to resolve such discordant results.


2021 ◽  
Vol 70 (21) ◽  
pp. 794-795
Author(s):  
Shirley Lee Lecher ◽  
Mary Naluguza ◽  
Christina Mwangi ◽  
Jonathan N’tale ◽  
Dianna Edgil ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (12) ◽  
pp. e113813 ◽  
Author(s):  
Kimberly Bonner ◽  
Reed A. Siemieniuk ◽  
Andrew Boozary ◽  
Teri Roberts ◽  
Emmanuel Fajardo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document